MBOT Stock Analysis: Buy, Sell, or Hold?
MBOT - Microbot Medical, Inc. Common Stock
$1.97
-0.04 (-1.99%)
▼
5d:
+15.2%
30d:
-6.64%
90d:
-19.59%
BUY
HIGH Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When MBOT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called MBOT this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MBOT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: MBOT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: MBOT is currently trading at $1.97, which is considered fair relative to its 30-day fair value range of $1.82 to $2.15. From a valuation perspective, the stock is trading at a discount (Forward PE: -7.0) compared to its historical average (18.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MBOT is in a strong uptrend. Immediate support is located at $1.66, while resistance sits at $2.17.
Market Sentiment: MBOT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+331.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MBOT is in a strong uptrend. Immediate support is located at $1.66, while resistance sits at $2.17.
Market Sentiment: MBOT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+331.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.82 -
$2.15
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
88.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 331.5% below Wall St target ($8.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$1.82 -
$2.15
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.66
Resistance Level
$2.18
Current Trend
Strong Uptrend
Technical data as of
Jun 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.04
Wall Street Target
$8.50
(+331.5%)
PE vs Historical
-7.0 vs 18.5
CHEAP
Share & Embed Analysis
Last updated: June 03, 2026 5:57 PM ET
Data refreshes hourly during market hours. Next update: 6:57 PM
Data refreshes hourly during market hours. Next update: 6:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MBOT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$573 | 50 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 52 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$179 | 55 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$350 | 62 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$271 | 59 HOLD |
